Skip to content

Company

Adaptyv Bio

Biotech firm offering contract wet-lab services that synthesize designed proteins and measure their binding affinity for researchers.

Known aliases

  • Adaptyv Bio

Current stories

leadershipConfirmed3 publishers

Anthropic cuts Fable 5.1 prices by 25% and launches two-tier safeguard system with Mythos 5.1

The saving comes off cache reads, so it lands unevenly across teams, and the model's most sensitive capability now reaches users through a credential issued by an access program, not a purchase order a budget holder can sign off alone. Both changes move the decision away from the budget holder.

Perspective Coverage

3 publishers
Builder
Builder 37%
Operator
Operator 25%
Investor
Investor 38%

Reality

Evidence55
Adoption30
Hype gap+35
Incentives65
Confidence60
productOne report1 publisher

Anthropic's protein binders got tested by outside labs. The benchmark is still Anthropic's.

Two contract labs made and tested Claude's designs, which is genuinely new. The field baseline those results are scored against comes from the company that ran the experiment.

Publishers:thenextweb.com

Reality

Evidence42
Adoption20
Hype gap+25
Incentives82
Confidence45
buildOne report1 publisher

That 34.3% TREM2 Hit Rate Belongs To Six Agents, Not To Claude

A one-day hackathon put agent-designed binders through Adaptyv Bio's wet-lab screen. The durable result is that the designs cleared a shared assay at all, not that any single model won.

Publishers:dev.to

Reality

Evidence38
Adoption14
Hype gap+12
Incentives66
Confidence40